Voyageur Pharmaceuticals Ltd. announced a significant advancement in its partnership with Rain Cage Carbon Inc. This milestone signifies the execution of a royalty agreement that solidifies the exclusive development and license agreement between the parties and it further reinforces Voyageur's commitment to pioneering sustainable carbon drug development. Driving Innovation in Healthcare Imaging Voyageur and Rain Cage have solidified their strategic alliance and are poised to redefine healthcare imaging technologies. The execution of the royalty agreement underscores their shared dedication to leveraging Rain Cage's pioneering EDENTM carbon capture technology for the creation of innovative nanocarbon/fullerene-based imaging drugs.

Building an Eco-Friendly Drug Pipeline In alignment with its sustainable goals, Voyageur is forging ahead with the establishment of an eco-friendly drug pipeline. This pipeline includes barium sulfate contrast media, iodinated contrast media, and carbon contrast media products, forming an integral part of Voyageur's Earth to Bottle strategic business plan. Pioneering MRI Drug Development With a focus on innovation, Voyageur is spearheading the development of a new MRI drug utilising the V@C60 molecule.

This breakthrough holds promise for revolutionizing MRI imaging as well as facilitating targeted drug delivery of contrast agents to specific areas of the body. Sustainable Carbon Production for Future Growth Building upon Rain Cage's breakthrough in carbon production from captured CO 2, Voyageur is poised for sustainable growth. The preparation of a carbon production Revenue Sharing Agreement is underway to exploit carbon captured and leverage the cash flow generated by carbon production technology at Voyageur's future pharmaceutical manufacturing facility.

Voyageur is evaluating several existing pharmaceutical facilities, to enable the vertical integration of its pharmaceutical projects and align with its vision of integrating sustainability into pharmaceutical production. Leading the Way in Pharmaceutical Sustainability Voyageur's partnership with Rain Cage underscores its leadership in sustainable pharmaceutical development. By executing the royalty agreement and advancing eco-friendly drug development, Voyageur is contributing to a healthier future and a greener planet.